Directa Plus PLC Directa Plus receives two new Italian patents

TIDMDCTA

Directa Plus PLC

29 June 2023

RNS Reach

29 June 2023

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

Directa Plus receives two new Italian patents

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, has been granted two new Italian patents, the EP patent, which relates to the 'apparatus for treating materials with plasma', and the ET patent, which relates to the 'composition comprising graphene for the treatment of textile articles'.

These new grants represent a step forward in Directa Plus' intellectual property strategy and protects the Company's unique production process and the evolution of its graphene technology. Following the grant of the two patents, Directa Plus' IP portfolio now comprises of 22 patent families, with 84 patents granted and 38 patents pending.

EP patent

Covers the apparatus for treating materials with plasma, in particular a device comprising a plasma microwave generator, a waveguide, and a microwave system torch, suitable for generating and sustaining atmospheric thermal plasma for treating powder materials. This is key to the Group's IP strategy as plasma technology sits at the core of Directa Plus' unique production process and is what distinguishes the Company from its competitors. Through its plasma technology, Directa Plus generates super-expanded graphite (Grafysorber(R)) with unique properties and performances in a chemical-free process. The EP patent is the technical evolution of the patent for 'production of nano-structures', and covers all the engineering improvements made to the plasma system to enhance the performance of the technology in terms of yields and the quality of the super expanded graphite obtained. The patent priority date is 19 December 2018.

ET Patent

Covers the composition for treating textile articles and is a further evolution of the use of G+ in textiles, expanding the Group's patent coverage in textile applications. It covers a 100% natural and environmentally sustainable printing paste enhanced by graphene's antimicrobial, electrical and thermal conductivity properties. The patent also protects textile articles treated with the composition, including manufactured products for personal health protection. The natural make-up of this composition firmly aligns with Directa Plus' focus on sustainability and environmental protection. T he patent priority date is the 4 May 2021.

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said : "Receiving a further two patents has not only strengthened Directa Plus' IP portfolio but demonstrates the ability of our graphene technology to be used across a range of applications and reinforces our position in fast growing markets. As we look to further our competitive advantage, we will continue to aggressively expand our portfolio, covering both technology and applications."

For further information please visit http://www.directa-plus.com/ or contact:

 
 Directa Plus plc                             +39 02 36714458 
 Giulio Cesareo, CEO 
 Giorgio Bonfanti, CFO 
 
 Cenkos Securities plc (Nominated Adviser 
  and Joint Broker)                           +44 131 220 6939 
 Neil McDonald 
 Adam Rae 
 
 Singer Capital Markets Securities Limited 
  (Joint Broker)                              +44 20 7496 3069 
 Rick Thompson 
 Phil Davies 
 
 Alma PR (Financial PR Adviser)               +44 20 3405 0205 
 Justine James                                directaplus@almapr.co.uk 
 Hannah Campbell 
 Kinvara Verdon

Notes to Editors

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products.

Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+(R)) have multiple applications due to its properties. These G+(R) products can be categorised into various families, with different products being suitable for specific practical applications.

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. Directa Plus holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAUWORRORUNUUR

(END) Dow Jones Newswires

June 29, 2023 02:00 ET (06:00 GMT)

Directa Plus (LSE:DCTA)
Historical Stock Chart
From Dec 2024 to Jan 2025